Plasma cytokine levels characterize disease pathogenesis and treatment response in tuberculosis patients.

Monika M VivekanandanErnest AdankwahWilfred AniagyeiIsaac AcheampongAugustine YeboahJoseph F ArthurMillicent N K LampteyMohammed K AbassAmidu GawusuFrancis KumbelFrancis Osei-YeboahLinda Batsa DebrahDorcas O OwusuAlexander DebrahErtan MayatepekJulia SeyfarthRichard O PhillipsMarc Jacobsen

Published in: Infection (2022)

Combinations of different plasma cytokine (namely, IL-6, IL-10, and IP-10) efficiently classified tuberculosis patients with differential mycobacterial burden and especially IL-6 qualified as a biomarker candidate for early treatment response.

Keyphrases

mycobacterium tuberculosis
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
pulmonary tuberculosis
peritoneal dialysis
prognostic factors
risk factors
patient reported outcomes
hepatitis c virus